NISCHR AHSC Presentations

advertisement

A successful collaboration between

Huntleigh and Cardiff NHS Podiatry Department www.cymru.gov.uk

Dr Jane Lewis,

Clinical Specialist and Research Podiatrist

 The Diagnostic Products Division of Huntleigh has over 25 years experience in design, development, manufacturing and marketing non-invasive electro-diagnostic products to the global medical market

 Award winning innovators in medical technology

– 1982, 1987, 1992 Queen’s Award for Export (Medical Systems)

– 1993 Queen’s Award for Technological Achievement (Doppler range)

– 2003 Queen’s Award for Innovation (Vascular Assist range)

– 2009 MediWales NHS Partnership with Academia and Industry Award

(Ability)

– 2010 IET Innovation Award – Highly Commended (Ability)

 Long standing relationship working with the NHS

 Globally established training programmes in Peripheral Arterial

Disease

Peripheral Arterial Disease

 In Europe and North America an estimated 27 million people have

Peripheral Arterial Disease (PAD) and in the UK around 100,000 people are diagnosed every year.

 PAD patients 6x more likely to die from Coronary Heart Disease

(CHD)

(Belch et al, 2007, Br J Diabetes Vasc Dis 7(5): 236-239)

 In 2012, estimated that 17% of pop (102m) will be > 65 and at high risk of leg/foot ulcers

 Approximately 20% of population > 65 are asymptomatic PAD

 Inadequate primary care vascular assessments

 Up to 33% inappropriate referrals to Vascular Team (back pain, neurological pain, nerve entrapment)

Detection of PAD is paramount and potentially treatable

 Large body of evidence supporting the efficacy of Ankle Brachial

Index (ABI) as an effective diagnostic and risk assessment tool

(Newman, 1999: Papamicheal, 2000: Sikkink, 1997: Zheng, 1997)

 To date, ABI is the most effective, accurate and practical method of PAD detection

(Belch et al, 2003)

 ABI < 0.9 is 95% sensitive in detecting angiogram positive disease and almost 100% specific in excluding healthy individuals

 ABI < 0.9 is highly predictive of morbidity and mortality from cardiovascular events linked with PAD (Belch et al, 2003)

 ABI also provides information regarding severity of PAD that can assist in guiding a treatment approach

Early Collaboration

 In 2002, Huntleigh had previously supported Jane Lewis in her PhD research, funded by the WAG.

 This work used the Vascular Assist for detecting PAD in diabetic patients using ABI, toe pressures and Pulse Volume Recordings

(PVR).

 It concluded that:

 advancements in ABI measurements are needed

 PVR had clinical value in assessing diabetic patients with calcified arteries.

Vascular

Assist

Aim of the New Development

 In 2008, Huntleigh decided to develop a device that would quickly and easily measure the ABI, not based on the Doppler technique.

 The new device should:

 be automatic and easy to use

 portable

 require minimal training

 be clinically reliable

 have quantifiable results

 eliminate the need to rest the patient

 allow early identification of PAD and intervention

Two Chamber Cuffs

An innovative two chamber cuff was designed to detect systolic pressures based on PVR technology

Dr Jon

Evans

Coinventors

Dr Nigel

Gough

The Ability Prototype Unit

 Developed a laptop based prototype

 Birth of

Automatic A nkle B rachial I ndex

System

 Tried on volunteers

 Needed to be clinically tested

 Cuff design improvements

 Consulted Cardiff Podiatry

Department

Purpose of the study

Clinical Performance

Study

To evaluate the efficacy of the Ability unit for its agreement and time taken to conduct the test when compared with the current gold standard Doppler method for obtaining ABIs

Clinical involvement essential

 Regular brainstorming meetings

 Is study design practical/achievable?

 Is patient target group realistic?

 How easy will it be to recruit patients?

 Is inclusion/exclusion criteria too tight?

 Measurable study outcomes were agreed.

Clinical Performance

Study

 Utilised existing Podiatry vascular assessment clinics

 Few patients attending were found to be unsuitable for study

Sequence

A

Ability unrested

(timed)

Sequence

B

10 mins rest

10 mins rest

Ability rested

(timed)

5 mins rest

Doppler rested

(timed)

5 mins rest

Doppler rested

(timed)

Ability rested

(timed)

The Ability Prototype Unit and

Doppler in Use

Vascular

Assist

Ability data collection device – clinician blinded to the data collected

Results

Agreement of Unrested Ability and Rested Doppler

Bias = –0.064

95% limit of agreement = ± 0.22

Objective achieved: Agrees with

Doppler

Results

Agreement of Unrested and Rested Ability

Bias = –0.026

95% limit of agreement = ± 0.21

Objective achieved: No rest required

Results

Test Timings

Mean time

Ability

Unrested

7.1 min

Doppler

Rested

31.5 min

Summary of

Clinical Study

 Good agreement between Doppler and Ability

 The Ability measurement takes significantly less time than

Doppler and obviates the need for a rested patient by the simultaneous cuff inflation improving the whole patient experience

 The Ability has the potential to be used as a screening tool for

PAD in primary care settings by increasing the patient throughput and its simplicity allows it to be operated by a Healthcare

Support Worker.

 Allows earlier diagnosis and intervention for lifestyle changes and risk factors

 Study provided clinical evidence that the innovative technique worked

Collaboration with the Concept

Design

Local market research amongst potential users was undertaken to develop the correct concept design and its accessories.

Automatic A nkle B rachial I ndex

System

136

138

146

84

1.06

normal

ABI

0.61

moderate

PVR printout

Automatic A nkle B rachial I ndex

Two chamber cuffs are connected to the Ability unit

Collaboration with the Design of

Accessories

Developing the carry bag and trolley

Evaluating the Disposable Sleeves

Disposable sleeves

 For improved infection control

 Eliminates the need to clean cuffs

 Fits ankles and arms

Portability

Community

Clinic

Home visits

Hospital Clinic

Advantages of Local

Collaboration

 Regular succinct brainstorming meetings for:

 planning

 problem solving

 quick resolution of technical problems

 improving usability of the product

 reviewing risk analysis

 provided clinical input at many stages of the project

 Allowed for smooth running of study and more efficient data collection.

Future Collaboration

 Primary Care study with GP’s

 To reduce the number of referrals to secondary care

 To indentify the use of Ability as a cost effective assessment tool

 Funding opportunities are being sought

 Masters in Research (MRes) – PVR study

 Improve the identification of PVR waveforms

 How they correlate with the Doppler waveforms

 Secondary Care study – ABI and TBI vs Duplex scan

 How well ABI and TBI PAD diagnosis compares with Duplex scans

 Development of the large cuff design

Thank you for your Attention

Download